Brokerages Set Aquestive Therapeutics, Inc. (NASDAQ:AQST) Price Target at $10.67
Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Free Report) has received a consensus rating of “Buy” from the seven ratings firms that are presently covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month target […]
Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Free Report) has received a consensus rating of “Buy” from the seven ratings firms that are presently covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month target […]
